Mechanisms Underlying Efficacy of Prolonged Exposure (NCT05788302)
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this research is to collect pilot data that demonstrates that proposed neural, psychophysiological and subjective markers measured before, during, and after treatment change over the course of Prolonged Exposure therapy (PE) for posttraumatic stress disorder (PTSD). The aims of the study are to: (1) examine theoretically informed mechanisms as pretreatment predictors of PE treatment efficacy, (2) characterize how neural, psychophysiological, and subjective markers measured before, during, and after treatment change over the course of PE, and (3) examine proposed mechanisms of change as measures of PE treatment efficacy. This is a longitudinal study of predictors of exposure therapy efficacy that will be conducted within the context of a standard 10 session PE treatment trial, with independent multimodal assessment batteries administered at pre-treatment, mid-treatment, post-treatment, and at 1-month follow-up. This data will be used to support a future NIMH and/or VA grant submission.
Who can join: Review the eligibility criteria below.
Location: MGH — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
- Prolonged Exposure (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- MGH — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 643-6703
Email: AWBAKER1@PARTNERS.ORG
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Post Traumatic Stress Disorder
- A Study of Psilocybin for PTSD — Baltimore, Maryland
- RESILIENT : A Self-Managed Online Platform for Victims of Sexual Assault — Québec, Quebec
- Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder — New York, New York
- TMS-fNIRS Personalized Dosing — Tallahassee, Florida
- Targeted Plasticity Therapy for Posttraumatic Stress Disorder — Dallas, Texas
- NightWare and Cardiovascular Health in Women With PTSD — Aurora, Colorado
Explore by condition: All Post Traumatic Stress Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.